Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands |
Total |
Cumulative Effect, Period of Adoption, Adjustment |
Common Stock |
Paid-in Capital |
Accumulated Deficit |
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
|
Accumulated Other Comprehensive Income (Loss) |
Treasury Stock |
|---|---|---|---|---|---|---|---|---|
| Balance at beginning of period (in shares) at Nov. 03, 2019 | 23,738,003 | |||||||
| Balance at beginning of period at Nov. 03, 2019 | $ 36,189 | $ 22,216 | $ 2,374 | $ 77,688 | $ (10,917) | $ 22,216 | $ (6,801) | $ (26,155) |
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||
| Net income (loss) | (33,587) | (33,587) | ||||||
| Share-based compensation | 1,736 | 1,736 | ||||||
| Issuance of common stock | 977 | 513 | (7,505) | 7,969 | ||||
| Other comprehensive income | 343 | 343 | ||||||
| Balance at end of period (in shares) at Nov. 01, 2020 | 23,738,003 | |||||||
| Balance at end of period at Nov. 01, 2020 | 27,874 | $ 2,374 | 79,937 | (29,793) | (6,458) | (18,186) | ||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||
| Net income (loss) | 1,374 | 1,374 | ||||||
| Share-based compensation | 2,101 | 2,101 | ||||||
| Issuance of common stock | (465) | (1,976) | (3,789) | 5,300 | ||||
| Other comprehensive income | 209 | 209 | ||||||
| Balance at end of period (in shares) at Oct. 31, 2021 | 23,738,003 | |||||||
| Balance at end of period at Oct. 31, 2021 | $ 31,093 | $ 2,374 | $ 80,062 | $ (32,208) | $ (6,249) | $ (12,886) |